A5058318130- Dysphagia Assessment and Management
- Liver Disease Diagnosis and Treatment
- Nutrition and Health in Aging
- Liver Diseases and Immunity
- Hepatitis B Virus Studies
- Liver Disease and Transplantation
- Gastrointestinal motility and disorders
- Diet and metabolism studies
- Mycobacterium research and diagnosis
- Clinical Nutrition and Gastroenterology
- Microscopic Colitis
- Colorectal Cancer Screening and Detection
- Pediatric Hepatobiliary Diseases and Treatments
University of Campania "Luigi Vanvitelli"
2022-2025
Biological antioxidant potential (BAP) and Reactive Oxygen Metabolites (dROMs) are two tests complementarily assessing systemic oxidative statuses (SOSs) that never applied in chronic liver disorders (CLDs). We enrolled 41 ursodeoxycholic acid (UDCA)-naïve Primary Biliary Cholangitis (PBC) patients [age: 58.61 ± 11.26 years; females (F): 39], 40 with metabolic-dysfunction-associated steatotic livers (age: 54.30 11.21; F: 20), 52 HBV 52.40 8.22; 34), 50 56.44 7.79, 29), 10 controls 52.50...
The increased prevalence of irritable bowel syndrome (IBS) among medical and nursing students is a global challenge. Unfortunately, data on the Italian nurse student population are scarce. Therefore, this study was designed to assess IBS in setting evaluate demographic, university, Mediterranean diet adherence, anxiety factors associated with its presence.To IBS, levels, adherence university students.An anonymous online questionnaire sent participants. Several demographic educational...
BACKGROUND:There is a recognized association between inflammatory bowel disease (IBD) and hepatobiliary autoimmune disease, particularly primary sclerosing cholangitis (PSC). There have been fewer reported cases of IBD biliary (PBC), which treated with ursodeoxycholic acid (UDCA). This report presents the case 60-year-old woman PBC who was diagnosed Crohn’s ileitis after suspension UDCA treatment. CASE REPORT:A 66-year-old female patient admitted to our department for irrepressible chronic...